Kromek Share Discussion Threads

[aqc888] 01/6/2022 18:57

You’d think an investor would have clear evidence so that they could make their mind up if it worked or not. Why would that clear evidence not be available? Accreditation results they promised never released. Field trials they conducted not updated. Sales they promised not coming in.

Either it doesn’t work or they’re completely and utterly incompetent.

Given Kromeks history of the management being the latter, I still hold some hope the technology might actually work.

[slicethepie] 01/6/2022 07:36

In one sentence the pathogen detector doesn't work and in the next there is a small chance, make your mind up! Fwiw kmk presented this to a formidable ordience in January IMO DYOR GLASP

[33mick] 01/6/2022 07:25

Im not sure why's anyone would state that one companies medical CT scannars are inferior to another's.
Kromek's £57 million multi years contract to supply CZT equipment is for Philips almost certainly. and they are developing their own Photon Counting CT to release shortly from what I've read.

This article from last year..

[aqc888] 31/5/2022 23:29

Kromek has no value since it has no ability to make a profit. The hospital scanners are inferior to rival scanners. The biological pathogen detectors don’t work. The nuclear detectors are great but there’s no significant market or repeat orders for them. Kromek can sell the CZT other manufacturers need it would seem. But selling CZT and nuclear detectors doesn’t cover the CEOs spending requirements on new R&D. Hence the loss every year and constant fundraisings and need for government grants.
There’s a small chance the biological pathogen detector works and an order might come in for it. But a much bigger chance there’s no order and Kromek runs out of cash.

[33mick] 31/5/2022 22:41

Plus there's a lot of hospitals with old equipment due for replacement soon if this article is anything to go by.

[33mick] 31/5/2022 22:36

My thoughts exactly slicethepie.
The leap in medical imaging tech made possible with CZT and it's universal adoption by the major OEMs is never going to revert backwards it will only improve, the latest addition being AI to enhance the speed and accuracy again.the market is also larger than I realized with dental imaging, vetinary use and CT scans are very common in postmortems for help with cause of death and forensic examinations,.

[slicethepie] 31/5/2022 21:30

Our resident bears fail to understand that everything has value and the tide is turning for kmk. Clearly Basu has not delivered but he has built a business that has a value significantly higher than the current price generates. The fact that the end markets are slowly turning in their favour is an additional positive. Anyone who has dealt with the bodies that kmk deals with will know they are very slow at decision making. ALL IMHO. DYORSP

[strategicinvestor2] 31/5/2022 21:27

Yes things seem to be turning for the better for long suffering shareholders. GLA

[aqc888] 31/5/2022 21:07

Kromek was sat in the epicentre of a pandemic with a supposedly unique detector. To fail to deliver any profits whatsoever from such an achievement is remarkable. To think Kromek will achieve future success is a ridiculous folly. The board know it, and proved it, by not buying any at 8p. Where’s the independent proof these biological detectors work? No proof, no sales = it’s blindingly obvious they don’t work and were used to lure in money at the last desperate fundraising.

[slicethepie] 31/5/2022 07:53

Onwards and upwardsIMO DYOR GLASP

[senttothegallows] 31/5/2022 07:13

Kromek is currently sat right place right time right products. This will translate in to a significantly higher share price imho

[strategicinvestor2] 31/5/2022 04:03

Hopefully we will hear more with the results on where they are at on restructuring the company divisionally that would facilitate carve out and separate valuation or potential take over of different parts of the business. This seems a sensible move for shareholders. Any view or knowledge
on this ? Maybe already relatively separate ? IMHO DYOR

[aqc888] 27/5/2022 07:45

Does everyone who ever makes a post have to be a ramper or short? QP has been pro and anti Kromek over time, as have I. What’s driven the anti Kromek sentiment is the incompetence and misguidance of the board. There’s a possibility that things might turn around, but if it does, that turnaround will have nothing to do with the guidance the board issue. So much sheer nonsense has come out of their mouths, I’d rather have a donkey in the CEOs chair.

[b00mb0y] 26/5/2022 13:26

Can you repeat that please.

[slicethepie] 26/5/2022 12:51

He who POSTS negatively most when price is rising is normally short ?ouchALL IMHO. DYORSP

[quepassa] 26/5/2022 11:41

Remind me please.

What is their visibility on PROFITABILITY for the next years.

Because although they have MANY TIMES in the past said they have GOOD VISIBILITY on revenues - this has NEVER ONCE translated into profitability.

[slicethepie] 26/5/2022 11:26

He who posts negatively most when price is rising is normally short ...ouchALL IMHO. DYORSP

[quepassa] 26/5/2022 11:15

Remind me please.

What is their visibility on PROFITABILITY for the next years.

Because although they have MANY TIMES in the past said they have GOOD VISIBILITY on revenues - this has NEVER ONCE translated into profitability.

[strategicinvestor2] 26/5/2022 09:38

Was reassuring that they have visibility of nearly 100% of next years revenue taking into account the orders pipeline. Hopefully as we go through the year new orders not currently on the books can lead to upward revisions. Let’s pray for a turnaround here. GLA IMHO DYOR

[quepassa] 26/5/2022 09:31

The most important and basic thing that every investor knows who invests in highly speculative, small-cap or penny shares.

The absolute and vital importance that management have skin in the game. If they don't, their interests ARE NOT aligned with shareholders.

They get the risk-free fat salaries with no downside risk to their personal wealth whilst shareholders take all the downside risk.

It's the first rule which Nassim Taleb (renowned author of The Black Swan) expounds in his book, Skin in The Game.

The essential need for sharing of both downside and upside risk between shareholders and management.


ALL IMO. DYOR.
QP

[aqc888] 26/5/2022 08:44

So robust that he didn’t take the opportunity to top up at 8p! Don’t think there’s been an investor update in the last 5yrs of failure where there wasn’t imminent good news!

[quepassa] 26/5/2022 08:44

So why isn't the CEO buying then??


No real skin in the game.

It's always re-assuring to see a CEO eat their own cooking. Not so reassuring when they don't.


More shareholder dilution is in my opinion likely coming given massive £10m cash burn over 12 months.


ALL IMO. DYOR.
QP

[slicethepie] 25/5/2022 10:55

Onwards and upwards!ALL IMO. DYOR.SP